{"id":45190,"date":"2025-10-29T17:34:39","date_gmt":"2025-10-29T09:34:39","guid":{"rendered":"https:\/\/flcube.com\/?p=45190"},"modified":"2025-10-29T17:34:39","modified_gmt":"2025-10-29T09:34:39","slug":"bioray-pharmaceutical-co-ltd-signs-mena%e2%80%91wide-licensing-deal-with-saudi-tabuk-pharmaceutical-manufacturing","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=45190","title":{"rendered":"BioRay Pharmaceutical Co., Ltd. Signs MENA\u2011Wide Licensing Deal With Saudi Tabuk Pharmaceutical Manufacturing"},"content":{"rendered":"\n<p><strong>BioRay Pharmaceutical Co., Ltd.<\/strong> today announced the execution of a comprehensive license, supply, and commercialization agreement with <strong>Tabuk Pharmaceutical Manufacturing Company<\/strong> (Tabuk), a leading Saudi Arabian pharmaceutical firm. Under the terms, Tabuk will assume responsibility for regulatory registration and commercial roll\u2011out of BioRay\u2019s biosimilar portfolio across multiple Middle East and North Africa (MENA) markets.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-agreement-highlights\"><strong>Agreement Highlights<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>License &amp; Supply<\/strong> \u2013 BioRay grants Tabuk exclusive rights to manufacture, distribute, and market its biosimilar products in the agreed\u2011upon MENA territories.<\/li>\n\n\n\n<li><strong>Regulatory Stewardship<\/strong> \u2013 Tabuk will lead all registration dossiers, liaise with local authorities, and secure marketing authorizations for each product.<\/li>\n\n\n\n<li><strong>Commercial Strategy<\/strong> \u2013 Joint commercial plans will leverage Tabuk\u2019s established sales network and BioRay\u2019s clinical data to accelerate market penetration.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-rationale\"><strong>Strategic Rationale<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Saudi Arabia\u2019s Vision<\/strong> \u2013 The Kingdom\u2019s per\u2011capita healthcare spending is the highest in the Middle East, and its population growth rate remains the fastest in the Gulf. Saudi policy now strongly encourages domestic biotechnology and biopharmaceutical development.<\/li>\n\n\n\n<li><strong>Regional Expansion<\/strong> \u2013 The partnership positions BioRay to quickly scale its biosimilar offerings across a high\u2011growth region, while Tabuk gains access to a proven product pipeline that aligns with national health\u2011sector priorities.<\/li>\n\n\n\n<li><strong>Competitive Edge<\/strong> \u2013 By combining BioRay\u2019s clinical expertise with Tabuk\u2019s regulatory and distribution capabilities, the alliance is poised to capture market share in a rapidly liberalizing MENA pharmaceutical landscape.<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This release contains forward\u2011looking statements that involve risks and uncertainties. Actual results may differ materially.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>BioRay Pharmaceutical Co., Ltd. today announced the execution of a comprehensive license, supply, and commercialization&#8230;<\/p>\n","protected":false},"author":1,"featured_media":45192,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[2575,2722],"class_list":["post-45190","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-bioray-pharmaceutical","tag-tabuk-pharmaceutical-manufacturing-company"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>BioRay Pharmaceutical Co., Ltd. Signs MENA\u2011Wide Licensing Deal With Saudi Tabuk Pharmaceutical Manufacturing - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"BioRay Pharmaceutical Co., Ltd. (Shanghai\u2011based) today announced the execution of a comprehensive license, supply, and commercialization agreement with Tabuk Pharmaceutical Manufacturing Company (Tabuk), a leading Saudi Arabian pharmaceutical firm. Under the terms, Tabuk will assume responsibility for regulatory registration and commercial roll\u2011out of BioRay\u2019s biosimilar portfolio across multiple Middle East and North Africa (MENA) markets.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=45190\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioRay Pharmaceutical Co., Ltd. Signs MENA\u2011Wide Licensing Deal With Saudi Tabuk Pharmaceutical Manufacturing\" \/>\n<meta property=\"og:description\" content=\"BioRay Pharmaceutical Co., Ltd. (Shanghai\u2011based) today announced the execution of a comprehensive license, supply, and commercialization agreement with Tabuk Pharmaceutical Manufacturing Company (Tabuk), a leading Saudi Arabian pharmaceutical firm. Under the terms, Tabuk will assume responsibility for regulatory registration and commercial roll\u2011out of BioRay\u2019s biosimilar portfolio across multiple Middle East and North Africa (MENA) markets.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=45190\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-29T09:34:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2910.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45190#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45190\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"BioRay Pharmaceutical Co., Ltd. Signs MENA\u2011Wide Licensing Deal With Saudi Tabuk Pharmaceutical Manufacturing\",\"datePublished\":\"2025-10-29T09:34:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45190\"},\"wordCount\":261,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45190#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2910.webp\",\"keywords\":[\"BioRay Pharmaceutical\",\"TABUK Pharmaceutical Manufacturing Company\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=45190#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45190\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=45190\",\"name\":\"BioRay Pharmaceutical Co., Ltd. Signs MENA\u2011Wide Licensing Deal With Saudi Tabuk Pharmaceutical Manufacturing - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45190#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45190#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2910.webp\",\"datePublished\":\"2025-10-29T09:34:39+00:00\",\"description\":\"BioRay Pharmaceutical Co., Ltd. (Shanghai\u2011based) today announced the execution of a comprehensive license, supply, and commercialization agreement with Tabuk Pharmaceutical Manufacturing Company (Tabuk), a leading Saudi Arabian pharmaceutical firm. Under the terms, Tabuk will assume responsibility for regulatory registration and commercial roll\u2011out of BioRay\u2019s biosimilar portfolio across multiple Middle East and North Africa (MENA) markets.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45190#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=45190\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45190#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2910.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2910.webp\",\"width\":1080,\"height\":608,\"caption\":\"BioRay Pharmaceutical Co., Ltd. Signs MENA\u2011Wide Licensing Deal With Saudi Tabuk Pharmaceutical Manufacturing\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45190#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioRay Pharmaceutical Co., Ltd. Signs MENA\u2011Wide Licensing Deal With Saudi Tabuk Pharmaceutical Manufacturing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"BioRay Pharmaceutical Co., Ltd. Signs MENA\u2011Wide Licensing Deal With Saudi Tabuk Pharmaceutical Manufacturing - Insight, China&#039;s Pharmaceutical Industry","description":"BioRay Pharmaceutical Co., Ltd. (Shanghai\u2011based) today announced the execution of a comprehensive license, supply, and commercialization agreement with Tabuk Pharmaceutical Manufacturing Company (Tabuk), a leading Saudi Arabian pharmaceutical firm. Under the terms, Tabuk will assume responsibility for regulatory registration and commercial roll\u2011out of BioRay\u2019s biosimilar portfolio across multiple Middle East and North Africa (MENA) markets.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=45190","og_locale":"en_US","og_type":"article","og_title":"BioRay Pharmaceutical Co., Ltd. Signs MENA\u2011Wide Licensing Deal With Saudi Tabuk Pharmaceutical Manufacturing","og_description":"BioRay Pharmaceutical Co., Ltd. (Shanghai\u2011based) today announced the execution of a comprehensive license, supply, and commercialization agreement with Tabuk Pharmaceutical Manufacturing Company (Tabuk), a leading Saudi Arabian pharmaceutical firm. Under the terms, Tabuk will assume responsibility for regulatory registration and commercial roll\u2011out of BioRay\u2019s biosimilar portfolio across multiple Middle East and North Africa (MENA) markets.","og_url":"https:\/\/flcube.com\/?p=45190","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-10-29T09:34:39+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2910.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=45190#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=45190"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"BioRay Pharmaceutical Co., Ltd. Signs MENA\u2011Wide Licensing Deal With Saudi Tabuk Pharmaceutical Manufacturing","datePublished":"2025-10-29T09:34:39+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=45190"},"wordCount":261,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=45190#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2910.webp","keywords":["BioRay Pharmaceutical","TABUK Pharmaceutical Manufacturing Company"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=45190#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=45190","url":"https:\/\/flcube.com\/?p=45190","name":"BioRay Pharmaceutical Co., Ltd. Signs MENA\u2011Wide Licensing Deal With Saudi Tabuk Pharmaceutical Manufacturing - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=45190#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=45190#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2910.webp","datePublished":"2025-10-29T09:34:39+00:00","description":"BioRay Pharmaceutical Co., Ltd. (Shanghai\u2011based) today announced the execution of a comprehensive license, supply, and commercialization agreement with Tabuk Pharmaceutical Manufacturing Company (Tabuk), a leading Saudi Arabian pharmaceutical firm. Under the terms, Tabuk will assume responsibility for regulatory registration and commercial roll\u2011out of BioRay\u2019s biosimilar portfolio across multiple Middle East and North Africa (MENA) markets.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=45190#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=45190"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=45190#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2910.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2910.webp","width":1080,"height":608,"caption":"BioRay Pharmaceutical Co., Ltd. Signs MENA\u2011Wide Licensing Deal With Saudi Tabuk Pharmaceutical Manufacturing"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=45190#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"BioRay Pharmaceutical Co., Ltd. Signs MENA\u2011Wide Licensing Deal With Saudi Tabuk Pharmaceutical Manufacturing"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2910.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45190","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=45190"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45190\/revisions"}],"predecessor-version":[{"id":45193,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45190\/revisions\/45193"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/45192"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=45190"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=45190"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=45190"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}